CN103610964A - Medicine for treating recurrent oral ulcer - Google Patents
Medicine for treating recurrent oral ulcer Download PDFInfo
- Publication number
- CN103610964A CN103610964A CN201310583331.8A CN201310583331A CN103610964A CN 103610964 A CN103610964 A CN 103610964A CN 201310583331 A CN201310583331 A CN 201310583331A CN 103610964 A CN103610964 A CN 103610964A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- rhizoma
- recurrent oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a medicine for treating recurrent oral ulcer, which is prepared from the following raw materials in parts by weight: 20-30 parts of gypsum, 6-10 parts of rhizoma anemarrhenae, 6-9 parts of Baikal skullcap root, 6-10 parts of coptis, 10-12 parts of gardenia, 10-20 parts of radix rehmanniae, 6-10 parts of gromwell, 10-20 parts of rhubarb and 10-20 parts of cogongrass rhizome. By selecting the 9 natural traditional Chinese medicines, the medicine for treating recurrent oral ulcer performs the functions of removing pathogenic heat from blood, purging intense heat and detoxicating, nourishing yin, moistening the lung, reinforcing the stomach, promoting salivation, transforming pathogen accumulation, cultivating qi, and the like under the synergetic effects of the active pharmaceutical ingredients, has an inhibiting action on viruses and bacteria, treats both the incidental and fundamental aspects, and has the advantages of favorable effect on treating recurrent oral ulcer and no toxic or side effect. The medicine has the advantages of simple preparation method, short treatment course and low cost and is convenient to take, and the effective rate is up to higher than 95%.
Description
Technical field
The present invention relates to Chinese medicine, specifically a kind of medicine for the treatment of recurrent oral ulceration.
Background technology
Recurrent oral ulceration is the highest a kind of disease of sickness rate in oral mucosa disease, also claims recurrent aphtha.It shows effect repeatedly, causalgia unbearably, simultaneously can cause multiple complications, as halitosis, dizziness, yellowish urine, constipation with dry stool etc.Be apt to occur in lip, cheek, lingual margin etc.The outbreak of recurrent oral ulceration has self limiting and periodically, and in situation about not being effectively treated, ulcer morbidity is and aggravates gradually trend, show effect more and more frequent, and ulcer surface gets more and more, and the ulcer lasting time lengthening of showing effect, does not heal for a long time.Recurrent oral ulceration brings very large misery and inconvenient not only to patient's live and work, repeatedly show effect and will directly affect the immunologic function of the whole body of patient more seriously for a long time, cause metabolism disorder endocrine disturbance, occur the General Symptomies such as heating, headache, dizzy, nauseating, unable, visual deterioration, eyeball pain, muscae volitantes, lymphadenectasis, severe patient can cause blind; Also can cause skin joint and internal organs only a few cancerates.
It is to take antibiotics as Anti-virus Mixture, penicillins, cefalexin that at present conventional treatment measure is applied more except oral vitamin C, A; Sulfonamides, as SD sheet; Erythromycin series, as erythromycin tablets etc.These methods can only be cured the symptoms, not the disease mostly, take in addition too many antibiotic harmful unhelpful, and abuse of antibiotics may cause resistance to be strengthened, and immune function of human body goes down, and cause Relapse rate difficult.The contrary Chinese medicine that uses has good effect to recurrent oral ulceration prevention and treatment.
The traditional Chinese medical science thinks, oral cavity is connected with throat, lung, stomach, for many circulation meridians are assembled place, therefore recurrent oral ulceration is many, by accumulation of heat in the heart and spleen, hyperactivity of fire caused by deficiency of YIN, caused.Because of internal injury caused by excess of seven emotions, plain body is weak, and the heresy of diseases caused by exogenous pathogenic factor six climate exopathogens, causes stagnation of QI due to depression of the liver, hot and suffocating fire-transformation, and heart-fire is flourishing, rising up of the stomach-fire, disarmony between the heart and kidney, hyperactivity of deficient fire is fumigated in mouth and is fallen ill.Treatment recurrent oral ulceration should be in clearing away heat and cooling blood, pathogenic fire purging relieving constipation, change Yu Zhi gas for wanting.
Summary of the invention
The medicine of the treatment recurrent oral ulceration that the object of this invention is to provide a kind of good effect, the course for the treatment of is shorter, cost is low, has no side effect.
The technical scheme that realizes the object of the invention is:
Treating a medicine for recurrent oral ulceration, is to be made by the raw material of following weight proportioning:
Gypsum Fibrosum 20-30 part, Rhizoma Anemarrhenae 6-10 part, Radix Scutellariae 6-9 part, Rhizoma Coptidis 6-10 part, Fructus Gardeniae 10-12 part, Radix Rehmanniae 10-20 part, Radix Arnebiae (Radix Lithospermi) 6-10 part, Radix Et Rhizoma Rhei 10-20 part, Rhizoma Imperatae 10-20 part.
Preferably, the optimum weight proportioning of each raw material is:
25 parts of Gypsum Fibrosum, 8 parts of the Rhizoma Anemarrhenaes, 8 parts of Radix Scutellariaes, 8 parts of Rhizoma Coptidis, 11 parts of Fructus Gardeniaes, 15 parts, the Radix Rehmanniae, 8 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Radix Et Rhizoma Rhei, 15 parts of Rhizoma Imperataes.
Described crude drug in shop of Chinese medicines and market on sale.
The preparation method of medicine of the present invention, can decoct into decoction according to a conventional method, and concrete grammar is: take by weight ratio each crude drug, add the water of 5-10 times of crude drug total amount, boil rear slow fire boil 10-20 minute with big fire, filter and remove residue, obtains.
Instructions of taking: every day three times, each 30 milliliters, generally produce effect 6-8 day.
Medicine of the present invention also can be made into pill, powder or capsule.
In the present invention, the effect of each crude drug is as follows:
Gypsum Fibrosum: pungent, sweet, cold nature.Attach to the lung and stomach meridians.The effects such as have clearing away heat-fire, relieving restlessness is quenched the thirst, convergence granulation promoting.
The Rhizoma Anemarrhenae: bitter, sweet, cold in nature.Return lung, stomach, kidney channel.There is clearing away heat-fire, promote the production of body fluid and the effect such as moisturize.For fever caused by exogenous pathogenic factors, high hot excessive thirst, lung-heat type cough, osteopyrexia and fever, interior-heat is quenched one's thirst, dryness of the intestine constipation.
Radix Scutellariae: bitter, cold in nature.Return lung, gallbladder, spleen, stomach, large intestine, small intestine meridian.There is the effects such as heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive, blood pressure lowering.For hygropyrexia, fever disease in summer, vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, cough due to lung-heat, high hot excessive thirst, carbuncle sore tumefacting virus.
Rhizoma Coptidis: bitter in the mouth, cold in nature, GUIXIN, liver, stomach, large intestine channel.There is the effects such as clearing away heat-fire, dampness, removing toxic substances.
Fructus Gardeniae: bitter in the mouth, cold in nature, nontoxic, GUIXIN warp, Liver Channel, lung meridian, stomach warp, tri-jiao channel.Have pathogenic fire purging relieving restlessness, heat clearing away profit; The effects such as removing pathogenic heat from blood and toxic substance from the body.
The Radix Rehmanniae: sweet in the mouth, cold in nature, GUIXIN, liver, kidney channel.There is heat clearing away, promote the production of body fluid, moisturize, laxation, removing blood stasis with potent drugs, tissue regeneration promoting, pain relieving, regulating menstruation, the incised wound stasis of blood, removing heat from blood, the effect such as stop blooding, invigorate blood circulation.
Radix Arnebiae (Radix Lithospermi): sweet in the mouth, salty, cold in nature, GUIXIN, Liver Channel.There is the removing heat from blood of curing mainly, the effects such as rash of invigorating blood circulation, detoxify.For heat in blood poison contain, macule purple is black, measles without adequate eruption, skin infection, eczema, burn due to hot liquid or fire.
Radix Et Rhizoma Rhei: taste: hardship, cold in nature, return through spleen, stomach, large intestine, liver, pericardium channel.Have and attack the effects such as stagnant, clearing away damp-heat, pathogenic fire purging, removing heat from blood, blood stasis dispelling, removing toxic substances.
Rhizoma Imperatae: sweet-bitter flavor, cold in nature, nontoxic.Be included into lung, stomach, small intestine meridian.There is the effects such as removing heat from blood, hemostasis, heat clearing away, diuresis.
The present invention treats the medicine of recurrent oral ulceration and chooses 9 kinds of natural Chinese medicine compatibilities, each crude drug synergism plays the effects such as clearing away heat and cooling blood, eliminating fire and detoxication, nourishing YIN and moistening the lung, reinforcing stomach reg fluid, change Yu Zhi gas, virus and antibacterial are had to inhibitory action, treating both the principal and the secondary aspects of a disease at the same time, effective to treatment recurrent oral ulceration, have no side effect.And its preparation method is simple, the course for the treatment of is shorter, taking convenience, cost is low, and effective percentage reaches more than 95%.
The specific embodiment
Below in conjunction with embodiment, content of the present invention is further described, but is not limitation of the invention.
Embodiment 1:
Treat a medicine for recurrent oral ulceration, the weight proportion of each raw material is:
20 parts of Gypsum Fibrosum, 6 parts of the Rhizoma Anemarrhenaes, 6 parts of Radix Scutellariaes, 6 parts of Rhizoma Coptidis, 10 parts of Fructus Gardeniaes, 10 parts, the Radix Rehmanniae, 6 parts of Radix Arnebiae (Radix Lithospermi)s, 10 parts of Radix Et Rhizoma Rhei, 10 parts of Rhizoma Imperataes.Decoct into according to a conventional method decoction oral.
Embodiment 2:
Treat a medicine for recurrent oral ulceration, the weight proportion of each raw material is:
25 parts of Gypsum Fibrosum, 8 parts of the Rhizoma Anemarrhenaes, 8 parts of Radix Scutellariaes, 8 parts of Rhizoma Coptidis, 11 parts of Fructus Gardeniaes, 15 parts, the Radix Rehmanniae, 8 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Radix Et Rhizoma Rhei, 15 parts of Rhizoma Imperataes.Decoct into according to a conventional method decoction oral.
Embodiment 3:
Treat a medicine for recurrent oral ulceration, the weight proportion of each raw material is:
30 parts of Gypsum Fibrosum, 10 parts of the Rhizoma Anemarrhenaes, 9 parts of Radix Scutellariaes, 10 parts of Rhizoma Coptidis, 12 parts of Fructus Gardeniaes, 20 parts, the Radix Rehmanniae, 10 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Rhizoma Imperataes.Decoct into according to a conventional method decoction oral.
Experimental example:
In order further to prove the clinical efficacy of medicine of the present invention, select 30 routine patients, the curative effect of medicine of the present invention is carried out to clinical observation.
Efficacy determination be take transference cure as main, and with reference to change situations such as effects, is divided into effective, effective and invalid.
Effective: symptom obviously alleviates and successful improves.
Effective: symptom and effect have certain improvement.
Invalid: symptom and sign are all without improving or DeGrain.
Apply in Drug therapy recurrent oral ulceration 30 examples of the present invention male 12 examples, female's 18 examples.Fundamental symptoms is: halitosis, constipation, headache, dizziness, nauseating, weak, irritated, dispute many places ulcer, and wound surface swells and ache, more with tongue limit, and difficulty heals etc. repeatedly.After oral Drug therapy of the present invention, symptom all has certain improvement, effective 27 examples wherein, effective 30 examples, invalid 0 example, effective percentage 100%.
Claims (2)
1. treat a medicine for recurrent oral ulceration, it is characterized in that being made by the raw material of following weight proportioning:
Gypsum Fibrosum 20-30 part, Rhizoma Anemarrhenae 6-10 part, Radix Scutellariae 6-9 part, Rhizoma Coptidis 6-10 part, Fructus Gardeniae 10-12 part, Radix Rehmanniae 10-20 part, Radix Arnebiae (Radix Lithospermi) 6-10 part, Radix Et Rhizoma Rhei 10-20 part, Rhizoma Imperatae 10-20 part.
2. medicine according to claim 1, is characterized in that the weight proportion of each raw material is: 25 parts of Gypsum Fibrosum, 8 parts of the Rhizoma Anemarrhenaes, 8 parts of Radix Scutellariaes, 8 parts of Rhizoma Coptidis, 11 parts of Fructus Gardeniaes, 15 parts, the Radix Rehmanniae, 8 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Radix Et Rhizoma Rhei, 15 parts of Rhizoma Imperataes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310583331.8A CN103610964A (en) | 2013-11-20 | 2013-11-20 | Medicine for treating recurrent oral ulcer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310583331.8A CN103610964A (en) | 2013-11-20 | 2013-11-20 | Medicine for treating recurrent oral ulcer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103610964A true CN103610964A (en) | 2014-03-05 |
Family
ID=50161698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310583331.8A Pending CN103610964A (en) | 2013-11-20 | 2013-11-20 | Medicine for treating recurrent oral ulcer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103610964A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250762A (en) * | 2015-10-26 | 2016-01-20 | 林红丽 | Chinese herb composition for treating recurrent oral ulcer |
| CN107496726A (en) * | 2017-07-28 | 2017-12-22 | 刘道鹏 | A kind of aphtha electruary |
| CN109010634A (en) * | 2017-06-10 | 2018-12-18 | 鲍淳 | A kind of drug for treating recurrent aphthous ulcer |
-
2013
- 2013-11-20 CN CN201310583331.8A patent/CN103610964A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250762A (en) * | 2015-10-26 | 2016-01-20 | 林红丽 | Chinese herb composition for treating recurrent oral ulcer |
| CN109010634A (en) * | 2017-06-10 | 2018-12-18 | 鲍淳 | A kind of drug for treating recurrent aphthous ulcer |
| CN107496726A (en) * | 2017-07-28 | 2017-12-22 | 刘道鹏 | A kind of aphtha electruary |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103705883B (en) | One treats dermopathic medicine and preparation | |
| CN100434107C (en) | Acne clearing decoction | |
| CN100571731C (en) | A kind of Chinese medicine decoction for the treatment of herpes zoster | |
| CN103610964A (en) | Medicine for treating recurrent oral ulcer | |
| CN103830645A (en) | Oral liquid for treating halitosis | |
| CN104491825B (en) | A kind of Chinese medicine ointment for the treatment of oral ulcer | |
| CN103893625B (en) | One treats meningitic mixing Chinese medicine | |
| CN104225569A (en) | Chinese medicinal composition for treating chronic enteritis | |
| CN103263586B (en) | Traditional Chinese medicinal composition for treating mycotic enteritis | |
| CN103735798B (en) | A kind of Chinese medicine composition for the treatment of insufficiency of the spleen damp-heat type recurrent oral ulceration | |
| CN101574474A (en) | Traditional Chinese medicine composition for curing purpura | |
| CN106267075A (en) | A kind of Chinese medicinal capsule for treating ankylosing spondylitis | |
| CN105267777A (en) | Medicine for treating periodontitis | |
| CN101129875A (en) | Traditional Chinese medicine composition for treating infectiousness molluscum | |
| CN106110193A (en) | A kind of external skin ulcer convergence ointment and compound method thereof | |
| CN104998189A (en) | Traditional Chinese medicine powder for treating infantile oral ulcer of wind-heat spleen type and preparation method thereof | |
| CN101129849A (en) | Traditional Chinese medicine preparation for treating hemafecia | |
| CN105770115A (en) | Traditional Chinese medicine ointment for treating eczema | |
| CN104906352A (en) | Traditional Chinese medicine liquid for treating deficiency-fire flaring-up type infantile oral ulcer and preparation method thereof | |
| CN105561213A (en) | External application traditional Chinese medicine used for acute gouty arthritis | |
| CN104435232B (en) | A kind of Chinese medicine composition for treating toothache | |
| CN104225293A (en) | Traditional Chinese medicine disinfectant solution for clinical laboratory | |
| CN104491537A (en) | Traditional Chinese medicine composition for treating rheumatic heart disease | |
| CN104161846A (en) | Traditional Chinese medicine preparation for treating pyelonephritis | |
| CN104435556A (en) | Traditional Chinese medicine capsules for treating skin ulcer and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140305 |